🔎 Trials Near Me

Pradžia › Atopinis dermatitas (egzema) › Ohio

Atopinis dermatitas (egzema) klinikiniai tyrimai Ohio

10 tyrimai dėl Atopinis dermatitas (egzema) ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
  • Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
Renkami dalyviaiStebimasis tyrimas
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07290803

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Canton
  • Enveda Investigative Site, Mayfield Heights
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07298395

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  • Apex Clinical Research Center, LLC., Mayfield Heights
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Boardman
  • Investigational Site, Mason
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07003425

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • ClinOhio Research Services, Columbus
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-08-28 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 9, Columbus
  • Inmagene Site 5, Mayfield Heights
Renkami dalyviai2 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-12 · NCT07037901

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
  • Wright State Physicians Health Center /ID# 268841, Fairborn
Renkami dalyviai3 fazė
Amžius nuo 2 iki 11 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06461897

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

  • Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
Renkami dalyviai1 fazė
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT06504160

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  • Apex Clinical Research Center, Mayfield Heights
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-04 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7081, Dayton
Renkami dalyviaiStebimasis tyrimas
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-13 · NCT06988605

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.